Cost Of Wasted Eye Drops Counts As Harm, 3rd Circ. Told
Patients accusing Merck and other drugmakers of boosting prescription eye drop sales by using bottles that dispensed higher than necessary doses have told the Third Circuit their class claims should be...To view the full article, register now.
Already a subscriber? Click here to view full article